PPT-Drug treatments for dystonia and spasticity

Jane Hassell Paediatric Neurologist Kenya Paediatric Association Annual Scientific Conference 2019 Please do not film or take photos of the children shown in these slides These images were shared with the Faculty for teaching purposes only . Drugs for Muscle Spasm and Spasticity. Drugs for Muscle . Spasm and Spasticity. Two groups of drugs that cause skeletal muscle relaxation. One group for localized muscle spasm. Other group for spasticity. Spasticity gradually, reaching its maximum extent long after the initial injury occurs. Spasticity can cause pain and abnormal posture, as well as difficulty with movement, self - ca re, and other a C. ontrolling . spasticity. before it controls your loved . o. nes. Ileana Howard, MD. Rehabilitation Care Services. VA . Puget Sound Health Care. October 28, 2014. What is spasticity?. Why does . s. ITB Therapy. SM . (intrathecal baclofen therapy). Important Safety Information for ITB Therapy. SM. ITB Therapy (Intrathecal Baclofen Therapy) is indicated for use in the management of severe spasticity. Patients should first respond to a screening dose of intrathecal baclofen prior to consideration for long term infusion via an implantable pump. For spasticity of spinal cord origin, ITB Therapy via an implantable infusion system should be reserved for patients unresponsive to oral baclofen or those who experience intolerable CNS side effects at effective doses. Patients with spasticity due to traumatic brain injury should wait at least one year after the injury before consideration of long-term intrathecal baclofen therapy. . M. anagement in . N. on-malignant Neurological . D. isease. Dr. Emily HARROP. Consultant in Pediatric Palliative care. Introduction. Approaching Neurological symptoms from ‘first principles’. Practical aspects of neurological symptom management . Information for patients and families . Christopher Stephen, MD, MRCP (UK). Nutan. Sharma, MD, PhD. X-Linked . Dystonia. -Parkinsonism (XDP). - What is it?. Multiple names. XDP. DYT3 by dystonia classification. Principles of spasticity management. DYS-SE-000025 . Date of preparation. : May 2017. This programme is initiated and funded by IPSEN.. Dysport® (. Clostridium botulinum. type A toxin-haemagglutinin complex) prescribing information is available at this meeting.. Cerebral PalsyMegan Flanigan MD12 Deborah Gaebler-Spira MD12Christina Marciniak MD12Masha Kocherginsky PhD11Northwestern University Feinberg School of Medicine Chicago Il 2Shirley Ryan AbilityLab Chic Cervical Dystonia . P. atterned. , repetitive, and spasmodic or sustained muscle contractions resulting in abnormal movements and postures of the . head and neck . may affect any combination of neck . Page 1 of 24 UnitedHealthcare Commercial Medical Benefit Drug Policy Effective 0 7 / 01 / 2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHe Despite its prevalence, dystonia is under-recognized and therefore undertreated. By Rachel Dolhun, MD The Michael J. Fox Foundation for Parkinson’s Research Dystonia is the third most common mov Abstract Cervical dystonia (CD) is a chronic movement disorder characterised by abnormal postures of the neck. Although muscle contractions representthe most visible disease feature, associated sympto Dr . Digvijay. Sharma. Spasticity. Spasticity is one of the most common and potentially disabling and bothersome complications affecting individuals with Neurological conditions.. 1. Spasticity may be defined as a motor disorder characterized by a velocity-dependent exaggeration of stretch reflexes, resulting from abnormal . Rett. Syndrome from the . physiatry. Perspective. Laura L. Deon, MD. Rush University Medical Center. La . Rabida. Children’s. . Hospital. Introduction. Rett. syndrome is a unique developmental disorder caused by a MECP2 mutation that usually occurs in infant girls..